Induced Pluripotent Stem Cells (iPSCs) Market Report

USA Induced Pluripotent Stem Cells (iPSCs) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Sep 18, 2022
  • PAGES：214
  • REPORT CODE：GMM1215979
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Induced Pluripotent Stem Cells (iPSCs) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Induced Pluripotent Stem Cells (iPSCs) market. Detailed analysis of key players, along with key growth strategies adopted by Induced Pluripotent Stem Cells (iPSCs) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • ReproCELL

    • Fate Therapeutics, Inc

    • Astellas Pharma Inc

    • Pluricell Biotech

    • Ncardia

    • Cell Inspire Biotechnology

    • Fujifilm Holding Corporation (CDI)

    • Sumitomo Dainippon Pharma

    By Type:

    • Human iPSCs

    • Mouse iPSCs

    By End-User:

    • Academic Research

    • Drug Development and Discovery

    • Toxicity Screening

    • Regenerative Medicine

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Induced Pluripotent Stem Cells (iPSCs) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Human iPSCs from 2016 to 2027

      • 1.3.2 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Mouse iPSCs from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Academic Research from 2016 to 2027

      • 1.4.2 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Drug Development and Discovery from 2016 to 2027

      • 1.4.3 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Toxicity Screening from 2016 to 2027

      • 1.4.4 USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Regenerative Medicine from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Induced Pluripotent Stem Cells (iPSCs) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Induced Pluripotent Stem Cells (iPSCs) by Major Types

      • 3.4.1 Market Size and Growth Rate of Human iPSCs

      • 3.4.2 Market Size and Growth Rate of Mouse iPSCs

    4 Segmentation of Induced Pluripotent Stem Cells (iPSCs) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Induced Pluripotent Stem Cells (iPSCs) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Induced Pluripotent Stem Cells (iPSCs) in Academic Research

      • 4.4.2 Market Size and Growth Rate of Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery

      • 4.4.3 Market Size and Growth Rate of Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening

      • 4.4.4 Market Size and Growth Rate of Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine

    5 Market Analysis by Regions

    • 5.1 USA Induced Pluripotent Stem Cells (iPSCs) Production Analysis by Regions

    • 5.2 USA Induced Pluripotent Stem Cells (iPSCs) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis

    • 6.1 West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major Types

    • 6.2 West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major End-Users

    7 South USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis

    • 7.1 South USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major Types

    • 7.2 South USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major End-Users

    8 Middle West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis

    • 8.1 Middle West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major Types

    • 8.2 Middle West USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major End-Users

    9 Northeast USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis

    • 9.1 Northeast USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major Types

    • 9.2 Northeast USA Induced Pluripotent Stem Cells (iPSCs) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 ReproCELL

        • 10.1.1 ReproCELL Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Fate Therapeutics, Inc

        • 10.2.1 Fate Therapeutics, Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Astellas Pharma Inc

        • 10.3.1 Astellas Pharma Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Pluricell Biotech

        • 10.4.1 Pluricell Biotech Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Ncardia

        • 10.5.1 Ncardia Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Cell Inspire Biotechnology

        • 10.6.1 Cell Inspire Biotechnology Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Fujifilm Holding Corporation (CDI)

        • 10.7.1 Fujifilm Holding Corporation (CDI) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sumitomo Dainippon Pharma

        • 10.8.1 Sumitomo Dainippon Pharma Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Human iPSCs from 2016 to 2027

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Mouse iPSCs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Academic Research from 2016 to 2027

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Drug Development and Discovery from 2016 to 2027

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Toxicity Screening from 2016 to 2027

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Regenerative Medicine from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Induced Pluripotent Stem Cells (iPSCs) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Induced Pluripotent Stem Cells (iPSCs)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Induced Pluripotent Stem Cells (iPSCs) by Different Types from 2016 to 2027

    • Table Consumption Share of Induced Pluripotent Stem Cells (iPSCs) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Human iPSCs

    • Figure Market Size and Growth Rate of Mouse iPSCs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Induced Pluripotent Stem Cells (iPSCs) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Induced Pluripotent Stem Cells (iPSCs) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Academic Research

    • Figure Market Size and Growth Rate of Drug Development and Discovery

    • Figure Market Size and Growth Rate of Toxicity Screening

    • Figure Market Size and Growth Rate of Regenerative Medicine

    • Table USA Induced Pluripotent Stem Cells (iPSCs) Production by Regions

    • Table USA Induced Pluripotent Stem Cells (iPSCs) Production Share by Regions

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Production Share by Regions in 2016

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Production Share by Regions in 2021

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Production Share by Regions in 2027

    • Table USA Induced Pluripotent Stem Cells (iPSCs) Consumption by Regions

    • Table USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Regions

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Regions in 2016

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Regions in 2021

    • Figure USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Regions in 2027

    • Table West USA Induced Pluripotent Stem Cells (iPSCs) Consumption by Types from 2016 to 2027

    • Table West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types from 2016 to 2027

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2016

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2021

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2027

    • Table West USA Induced Pluripotent Stem Cells (iPSCs) Consumption by End-Users from 2016 to 2027

    • Table West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2016

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2021

    • Figure West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2027

    • Table South USA Induced Pluripotent Stem Cells (iPSCs) Consumption by Types from 2016 to 2027

    • Table South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types from 2016 to 2027

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2016

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2021

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2027

    • Table South USA Induced Pluripotent Stem Cells (iPSCs) Consumption by End-Users from 2016 to 2027

    • Table South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2016

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2021

    • Figure South USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2027

    • Table Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption by Types from 2016 to 2027

    • Table Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2016

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2021

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2027

    • Table Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2016

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2021

    • Figure Middle West USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2027

    • Table Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption by Types from 2016 to 2027

    • Table Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2016

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2021

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by Types in 2027

    • Table Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2016

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2021

    • Figure Northeast USA Induced Pluripotent Stem Cells (iPSCs) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of ReproCELL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ReproCELL

    • Figure Sales and Growth Rate Analysis of ReproCELL

    • Figure Revenue and Market Share Analysis of ReproCELL

    • Table Product and Service Introduction of ReproCELL

    • Table Company Profile and Development Status of Fate Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fate Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Fate Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Fate Therapeutics, Inc

    • Table Product and Service Introduction of Fate Therapeutics, Inc

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Pluricell Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pluricell Biotech

    • Figure Sales and Growth Rate Analysis of Pluricell Biotech

    • Figure Revenue and Market Share Analysis of Pluricell Biotech

    • Table Product and Service Introduction of Pluricell Biotech

    • Table Company Profile and Development Status of Ncardia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ncardia

    • Figure Sales and Growth Rate Analysis of Ncardia

    • Figure Revenue and Market Share Analysis of Ncardia

    • Table Product and Service Introduction of Ncardia

    • Table Company Profile and Development Status of Cell Inspire Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Inspire Biotechnology

    • Figure Sales and Growth Rate Analysis of Cell Inspire Biotechnology

    • Figure Revenue and Market Share Analysis of Cell Inspire Biotechnology

    • Table Product and Service Introduction of Cell Inspire Biotechnology

    • Table Company Profile and Development Status of Fujifilm Holding Corporation (CDI)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Holding Corporation (CDI)

    • Figure Sales and Growth Rate Analysis of Fujifilm Holding Corporation (CDI)

    • Figure Revenue and Market Share Analysis of Fujifilm Holding Corporation (CDI)

    • Table Product and Service Introduction of Fujifilm Holding Corporation (CDI)

    • Table Company Profile and Development Status of Sumitomo Dainippon Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma

    • Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma

    • Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma

    • Table Product and Service Introduction of Sumitomo Dainippon Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US